Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized, Open-Label Clinical Trial to Identify Predictive Factors for Controlled Ovarian Stimulation Using a Fixed Daily Dose of 200 IU Recombinant FSH in GnRH Antagonist Regimen With or Without Oral Contraceptive Scheduling

NCT00778999 is registered in ClinicalTrials.gov with Organon and Co as lead sponsor.

NCT NCT00778999
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00778999 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized, Open-Label Clinical Trial to Identify Predictive Factors for Controlled Ovarian Stimulation Using a Fixed Daily Dose of 200 IU Recombinant FSH in GnRH Antagonist Regimen With or Without Oral Contraceptive Scheduling
Lead sponsor
Organon and Co
Phase
Phase 4
Overall status
Completed
Start date
October 1, 2006
Completion date
July 24, 2008
Enrollment
442 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

infertility